account_balance
Investment manager · 13F filer · SEC CIK 1704132
Foresite Capital Management IV, LLC
Reported value$290Mas of Jun 30, 2026
Positions6 1 new, 3 sold out
Top 10 weight100.0%PHVS alone is 57%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 6 stocks.
PHVSPharvaris N.V.
57.0%
CYTKCytokinetics Inc
21.0%Added +42%
EIKNEikon Therapeutics, Inc.
8.7%
RLAYRelay Therapeutics, Inc.
8.1%Added +25%
XENEXenon Pharmaceuticals Inc.
3.3%
CRNX1.9%
Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 6 as a list
What changed